Blood Viscosity in COVID-19 Patients With Sudden Deafness
Changes in blood viscoelastic properties have been proposed previosuly as etiopathogenesis for severe complications in COVID-19 and some cases of Sudden Deafness (SD). This is an attempt to verify if SD cases in patients admitted for SARS-Cov-2 infection can be correlated. A prospective follow-up wa...
Gespeichert in:
| Veröffentlicht in: | Acta otorrinolaringológica española (English) 2022-03, Vol.73 (2), p.104-112 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 112 |
|---|---|
| container_issue | 2 |
| container_start_page | 104 |
| container_title | Acta otorrinolaringológica española (English) |
| container_volume | 73 |
| creator | García-Callejo, Francisco Javier Balaguer-García, Ramón Lis-Sancerni, María Dolores Ruescas-Gómez, Luis Murcia-López, Marta |
| description | Changes in blood viscoelastic properties have been proposed previosuly as etiopathogenesis for severe complications in COVID-19 and some cases of Sudden Deafness (SD). This is an attempt to verify if SD cases in patients admitted for SARS-Cov-2 infection can be correlated.
A prospective follow-up was carried out with COVID-19 patients, monitoring their blood viscosity (BV) at high shear rate (300 s−1) and inquiring them periodically for eventual hearing loss. This measurement was extended to cases bearing of SD in 2019 and 2020 without infection and a control group of healthy normoacoustic subjects.
The normality range was 4,16 ± 0,62 cps. 330 cases admitted for COVID-19 were evaluated from February 24th, 2020 to March 24th, 2021, 85 of them attended in ICU. After anamnesis and Audiometric Tone Thresholds developed as soon as possible, 9 SD were detected, all belonging to ICU group. The mean BV was 4,38 ± 0,43 cps in the ward group, 4,53 ± 0,39 cps in the ICU patients without SD, and 4,85 ± 0,52 cps in the cases with SD, with statistically significant differences. Highest BV elevations in the SD cases were detected between days 6 and 10 of hospital admission. In 2019 four cases consulted with SD, and another two did it in 2020 without a diagnosis of COVID-19, with normal BV values.
During SARS-Cov-2 infection, patients may show high BV and SS, although an inpatients control group and a larger sample volume are necessary to confirm the predisposition to hyperviscosity. The incidence of hearing damage is considerable if its possible appearance is taken into account, within the limitations of critical patients with COVID-19.
La alteración en las propiedades viscoelásticas de la sangre ha sido anteriormente propuesta como etiopatogenia de complicaciones severas por COVID-19 y algunos casos de Sordera Súbita (SS). Pretendemos verificar si la aparición de casos de SSI en pacientes ingresados por infección por SARS-Cov-2 puede correlacionarse de este modo.
Estudio longitudinal prospectivo de pacientes ingresados en nuestro Centro por COVID-19, efectuando monitorización de la viscosidad sanguínea (VS) a alta velocidad de cizallamiento (300 seg−1) y un requerimiento periódico personal sobre hipoacusia. Esta determinación se extendió a casos atendidos por SS sin infección en 2019 y 2020 y un grupo control de sujetos sanos normoacúsicos.
El rango de normalidad se situó en 4,16 ± 0,62 cps. Entre el 24 de Febrero de 2020 y el 24 de Marzo de 2021 se evaluaron 330 casos |
| doi_str_mv | 10.1016/j.otoeng.2022.02.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8864080</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2173573522000278</els_id><sourcerecordid>2649256625</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3084-a4f540258b9b8cc3e7a943875ca1132be5762e439305c3a10b2c13479dde4db93</originalsourceid><addsrcrecordid>eNp9kE1PAjEQhhujEYP8A2P26GWxn7vbi4mCHyQkmKh4bLrdAUqWLW4XEv69JSDixckk06Qz7zvzIHRFcJdgktzOu65xUE27FFPaxSExP0EXlKQsFikTp0fvFup4P8chEkGSlJ2jFhNMphmRF0g-lM4V0dh647xtNpGtot5oPOjHREavurFQNT76tM0selsVBVRRH_SkAu8v0dlElx46-9pGH0-P772XeDh6HvTuh7FhOOOx5hPBMRVZLvPMGAaplpxlqTCaEEZzEGlCgTPJsDBME5xTQxhPZTDjRS5ZG93tdJerfAGFCQvVulTL2i50vVFOW_X3p7IzNXVrlWUJxxkOAjd7gdp9rcA3ahGuhbLUFbiVVzThkookoSK08l2rqZ33NUwONgSrLXg1Vzvwagte4ZCYh7Hr4xUPQz-Yf2-AAGptoVbeBLIGCluDaVTh7P8O39x5lIU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2649256625</pqid></control><display><type>article</type><title>Blood Viscosity in COVID-19 Patients With Sudden Deafness</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>García-Callejo, Francisco Javier ; Balaguer-García, Ramón ; Lis-Sancerni, María Dolores ; Ruescas-Gómez, Luis ; Murcia-López, Marta</creator><creatorcontrib>García-Callejo, Francisco Javier ; Balaguer-García, Ramón ; Lis-Sancerni, María Dolores ; Ruescas-Gómez, Luis ; Murcia-López, Marta</creatorcontrib><description>Changes in blood viscoelastic properties have been proposed previosuly as etiopathogenesis for severe complications in COVID-19 and some cases of Sudden Deafness (SD). This is an attempt to verify if SD cases in patients admitted for SARS-Cov-2 infection can be correlated.
A prospective follow-up was carried out with COVID-19 patients, monitoring their blood viscosity (BV) at high shear rate (300 s−1) and inquiring them periodically for eventual hearing loss. This measurement was extended to cases bearing of SD in 2019 and 2020 without infection and a control group of healthy normoacoustic subjects.
The normality range was 4,16 ± 0,62 cps. 330 cases admitted for COVID-19 were evaluated from February 24th, 2020 to March 24th, 2021, 85 of them attended in ICU. After anamnesis and Audiometric Tone Thresholds developed as soon as possible, 9 SD were detected, all belonging to ICU group. The mean BV was 4,38 ± 0,43 cps in the ward group, 4,53 ± 0,39 cps in the ICU patients without SD, and 4,85 ± 0,52 cps in the cases with SD, with statistically significant differences. Highest BV elevations in the SD cases were detected between days 6 and 10 of hospital admission. In 2019 four cases consulted with SD, and another two did it in 2020 without a diagnosis of COVID-19, with normal BV values.
During SARS-Cov-2 infection, patients may show high BV and SS, although an inpatients control group and a larger sample volume are necessary to confirm the predisposition to hyperviscosity. The incidence of hearing damage is considerable if its possible appearance is taken into account, within the limitations of critical patients with COVID-19.
La alteración en las propiedades viscoelásticas de la sangre ha sido anteriormente propuesta como etiopatogenia de complicaciones severas por COVID-19 y algunos casos de Sordera Súbita (SS). Pretendemos verificar si la aparición de casos de SSI en pacientes ingresados por infección por SARS-Cov-2 puede correlacionarse de este modo.
Estudio longitudinal prospectivo de pacientes ingresados en nuestro Centro por COVID-19, efectuando monitorización de la viscosidad sanguínea (VS) a alta velocidad de cizallamiento (300 seg−1) y un requerimiento periódico personal sobre hipoacusia. Esta determinación se extendió a casos atendidos por SS sin infección en 2019 y 2020 y un grupo control de sujetos sanos normoacúsicos.
El rango de normalidad se situó en 4,16 ± 0,62 cps. Entre el 24 de Febrero de 2020 y el 24 de Marzo de 2021 se evaluaron 330 casos ingresados por COVID-19, 85 asistidos en UCI. Fueron identificadas tras anamnesis y ATL todo lo inmediata que el status clínico lo permitió hasta 9 casos con SS, todos pertenecientes al grupo de UCI. La VS media fue 4,38 ± 0,43 cps en el grupo de sala, 4,53 ± 0,39 cps en los pacientes en UCI sin SS, y 4,85 ± 0,52 cps en los casos con SS, con diferencias estadísticamente significativas. Las mayores elevaciones de la VS en los casos con SS se detectaron entre los días 6 y 10 del ingreso hospitalario. En 2019 consultaron 4 casos, y otros 2 en 2020 sin diagnóstico de COVID-19, con valores normales de VS.
Durante la infección por SARS-Cov-2 los pacientes pueden presentar elevación en la VS y SS, si bien se hacen necesarios un grupo control hospitalario y un volumen muestral mayor para confirmar la predisposición a la hiperviscosidad. La incidencia del daño auditivo resulta considerable si se tiene en cuenta su posible aparición en pacientes críticos con COVID-19.</description><identifier>ISSN: 2173-5735</identifier><identifier>EISSN: 2173-5735</identifier><identifier>DOI: 10.1016/j.otoeng.2022.02.004</identifier><identifier>PMID: 35397819</identifier><language>eng</language><publisher>Spain: Elsevier España, S.L.U</publisher><subject>Blood Viscosity ; COVID-19 ; COVID-19 - complications ; Hearing Loss, Sudden - diagnosis ; Hearing Loss, Sudden - etiology ; Hipoacusia neurosensorial ; Humans ; Original ; Prospective Studies ; SARS-CoV-2 ; Sensorineural hearingloss ; Sordera súbita ; Sudden deafness ; Viscosidad sanguínea</subject><ispartof>Acta otorrinolaringológica española (English), 2022-03, Vol.73 (2), p.104-112</ispartof><rights>2021 Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello</rights><rights>Copyright © 2021 Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello. Published by Elsevier España, S.L.U. All rights reserved.</rights><rights>2021 Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello. Published by Elsevier España, S.L.U. All rights reserved. 2021 Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3084-a4f540258b9b8cc3e7a943875ca1132be5762e439305c3a10b2c13479dde4db93</citedby><cites>FETCH-LOGICAL-c3084-a4f540258b9b8cc3e7a943875ca1132be5762e439305c3a10b2c13479dde4db93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35397819$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>García-Callejo, Francisco Javier</creatorcontrib><creatorcontrib>Balaguer-García, Ramón</creatorcontrib><creatorcontrib>Lis-Sancerni, María Dolores</creatorcontrib><creatorcontrib>Ruescas-Gómez, Luis</creatorcontrib><creatorcontrib>Murcia-López, Marta</creatorcontrib><title>Blood Viscosity in COVID-19 Patients With Sudden Deafness</title><title>Acta otorrinolaringológica española (English)</title><addtitle>Acta Otorrinolaringol Esp (Engl Ed)</addtitle><description>Changes in blood viscoelastic properties have been proposed previosuly as etiopathogenesis for severe complications in COVID-19 and some cases of Sudden Deafness (SD). This is an attempt to verify if SD cases in patients admitted for SARS-Cov-2 infection can be correlated.
A prospective follow-up was carried out with COVID-19 patients, monitoring their blood viscosity (BV) at high shear rate (300 s−1) and inquiring them periodically for eventual hearing loss. This measurement was extended to cases bearing of SD in 2019 and 2020 without infection and a control group of healthy normoacoustic subjects.
The normality range was 4,16 ± 0,62 cps. 330 cases admitted for COVID-19 were evaluated from February 24th, 2020 to March 24th, 2021, 85 of them attended in ICU. After anamnesis and Audiometric Tone Thresholds developed as soon as possible, 9 SD were detected, all belonging to ICU group. The mean BV was 4,38 ± 0,43 cps in the ward group, 4,53 ± 0,39 cps in the ICU patients without SD, and 4,85 ± 0,52 cps in the cases with SD, with statistically significant differences. Highest BV elevations in the SD cases were detected between days 6 and 10 of hospital admission. In 2019 four cases consulted with SD, and another two did it in 2020 without a diagnosis of COVID-19, with normal BV values.
During SARS-Cov-2 infection, patients may show high BV and SS, although an inpatients control group and a larger sample volume are necessary to confirm the predisposition to hyperviscosity. The incidence of hearing damage is considerable if its possible appearance is taken into account, within the limitations of critical patients with COVID-19.
La alteración en las propiedades viscoelásticas de la sangre ha sido anteriormente propuesta como etiopatogenia de complicaciones severas por COVID-19 y algunos casos de Sordera Súbita (SS). Pretendemos verificar si la aparición de casos de SSI en pacientes ingresados por infección por SARS-Cov-2 puede correlacionarse de este modo.
Estudio longitudinal prospectivo de pacientes ingresados en nuestro Centro por COVID-19, efectuando monitorización de la viscosidad sanguínea (VS) a alta velocidad de cizallamiento (300 seg−1) y un requerimiento periódico personal sobre hipoacusia. Esta determinación se extendió a casos atendidos por SS sin infección en 2019 y 2020 y un grupo control de sujetos sanos normoacúsicos.
El rango de normalidad se situó en 4,16 ± 0,62 cps. Entre el 24 de Febrero de 2020 y el 24 de Marzo de 2021 se evaluaron 330 casos ingresados por COVID-19, 85 asistidos en UCI. Fueron identificadas tras anamnesis y ATL todo lo inmediata que el status clínico lo permitió hasta 9 casos con SS, todos pertenecientes al grupo de UCI. La VS media fue 4,38 ± 0,43 cps en el grupo de sala, 4,53 ± 0,39 cps en los pacientes en UCI sin SS, y 4,85 ± 0,52 cps en los casos con SS, con diferencias estadísticamente significativas. Las mayores elevaciones de la VS en los casos con SS se detectaron entre los días 6 y 10 del ingreso hospitalario. En 2019 consultaron 4 casos, y otros 2 en 2020 sin diagnóstico de COVID-19, con valores normales de VS.
Durante la infección por SARS-Cov-2 los pacientes pueden presentar elevación en la VS y SS, si bien se hacen necesarios un grupo control hospitalario y un volumen muestral mayor para confirmar la predisposición a la hiperviscosidad. La incidencia del daño auditivo resulta considerable si se tiene en cuenta su posible aparición en pacientes críticos con COVID-19.</description><subject>Blood Viscosity</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>Hearing Loss, Sudden - diagnosis</subject><subject>Hearing Loss, Sudden - etiology</subject><subject>Hipoacusia neurosensorial</subject><subject>Humans</subject><subject>Original</subject><subject>Prospective Studies</subject><subject>SARS-CoV-2</subject><subject>Sensorineural hearingloss</subject><subject>Sordera súbita</subject><subject>Sudden deafness</subject><subject>Viscosidad sanguínea</subject><issn>2173-5735</issn><issn>2173-5735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PAjEQhhujEYP8A2P26GWxn7vbi4mCHyQkmKh4bLrdAUqWLW4XEv69JSDixckk06Qz7zvzIHRFcJdgktzOu65xUE27FFPaxSExP0EXlKQsFikTp0fvFup4P8chEkGSlJ2jFhNMphmRF0g-lM4V0dh647xtNpGtot5oPOjHREavurFQNT76tM0selsVBVRRH_SkAu8v0dlElx46-9pGH0-P772XeDh6HvTuh7FhOOOx5hPBMRVZLvPMGAaplpxlqTCaEEZzEGlCgTPJsDBME5xTQxhPZTDjRS5ZG93tdJerfAGFCQvVulTL2i50vVFOW_X3p7IzNXVrlWUJxxkOAjd7gdp9rcA3ahGuhbLUFbiVVzThkookoSK08l2rqZ33NUwONgSrLXg1Vzvwagte4ZCYh7Hr4xUPQz-Yf2-AAGptoVbeBLIGCluDaVTh7P8O39x5lIU</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>García-Callejo, Francisco Javier</creator><creator>Balaguer-García, Ramón</creator><creator>Lis-Sancerni, María Dolores</creator><creator>Ruescas-Gómez, Luis</creator><creator>Murcia-López, Marta</creator><general>Elsevier España, S.L.U</general><general>Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello. Published by Elsevier España, S.L.U</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202203</creationdate><title>Blood Viscosity in COVID-19 Patients With Sudden Deafness</title><author>García-Callejo, Francisco Javier ; Balaguer-García, Ramón ; Lis-Sancerni, María Dolores ; Ruescas-Gómez, Luis ; Murcia-López, Marta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3084-a4f540258b9b8cc3e7a943875ca1132be5762e439305c3a10b2c13479dde4db93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood Viscosity</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>Hearing Loss, Sudden - diagnosis</topic><topic>Hearing Loss, Sudden - etiology</topic><topic>Hipoacusia neurosensorial</topic><topic>Humans</topic><topic>Original</topic><topic>Prospective Studies</topic><topic>SARS-CoV-2</topic><topic>Sensorineural hearingloss</topic><topic>Sordera súbita</topic><topic>Sudden deafness</topic><topic>Viscosidad sanguínea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García-Callejo, Francisco Javier</creatorcontrib><creatorcontrib>Balaguer-García, Ramón</creatorcontrib><creatorcontrib>Lis-Sancerni, María Dolores</creatorcontrib><creatorcontrib>Ruescas-Gómez, Luis</creatorcontrib><creatorcontrib>Murcia-López, Marta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta otorrinolaringológica española (English)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García-Callejo, Francisco Javier</au><au>Balaguer-García, Ramón</au><au>Lis-Sancerni, María Dolores</au><au>Ruescas-Gómez, Luis</au><au>Murcia-López, Marta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood Viscosity in COVID-19 Patients With Sudden Deafness</atitle><jtitle>Acta otorrinolaringológica española (English)</jtitle><addtitle>Acta Otorrinolaringol Esp (Engl Ed)</addtitle><date>2022-03</date><risdate>2022</risdate><volume>73</volume><issue>2</issue><spage>104</spage><epage>112</epage><pages>104-112</pages><issn>2173-5735</issn><eissn>2173-5735</eissn><abstract>Changes in blood viscoelastic properties have been proposed previosuly as etiopathogenesis for severe complications in COVID-19 and some cases of Sudden Deafness (SD). This is an attempt to verify if SD cases in patients admitted for SARS-Cov-2 infection can be correlated.
A prospective follow-up was carried out with COVID-19 patients, monitoring their blood viscosity (BV) at high shear rate (300 s−1) and inquiring them periodically for eventual hearing loss. This measurement was extended to cases bearing of SD in 2019 and 2020 without infection and a control group of healthy normoacoustic subjects.
The normality range was 4,16 ± 0,62 cps. 330 cases admitted for COVID-19 were evaluated from February 24th, 2020 to March 24th, 2021, 85 of them attended in ICU. After anamnesis and Audiometric Tone Thresholds developed as soon as possible, 9 SD were detected, all belonging to ICU group. The mean BV was 4,38 ± 0,43 cps in the ward group, 4,53 ± 0,39 cps in the ICU patients without SD, and 4,85 ± 0,52 cps in the cases with SD, with statistically significant differences. Highest BV elevations in the SD cases were detected between days 6 and 10 of hospital admission. In 2019 four cases consulted with SD, and another two did it in 2020 without a diagnosis of COVID-19, with normal BV values.
During SARS-Cov-2 infection, patients may show high BV and SS, although an inpatients control group and a larger sample volume are necessary to confirm the predisposition to hyperviscosity. The incidence of hearing damage is considerable if its possible appearance is taken into account, within the limitations of critical patients with COVID-19.
La alteración en las propiedades viscoelásticas de la sangre ha sido anteriormente propuesta como etiopatogenia de complicaciones severas por COVID-19 y algunos casos de Sordera Súbita (SS). Pretendemos verificar si la aparición de casos de SSI en pacientes ingresados por infección por SARS-Cov-2 puede correlacionarse de este modo.
Estudio longitudinal prospectivo de pacientes ingresados en nuestro Centro por COVID-19, efectuando monitorización de la viscosidad sanguínea (VS) a alta velocidad de cizallamiento (300 seg−1) y un requerimiento periódico personal sobre hipoacusia. Esta determinación se extendió a casos atendidos por SS sin infección en 2019 y 2020 y un grupo control de sujetos sanos normoacúsicos.
El rango de normalidad se situó en 4,16 ± 0,62 cps. Entre el 24 de Febrero de 2020 y el 24 de Marzo de 2021 se evaluaron 330 casos ingresados por COVID-19, 85 asistidos en UCI. Fueron identificadas tras anamnesis y ATL todo lo inmediata que el status clínico lo permitió hasta 9 casos con SS, todos pertenecientes al grupo de UCI. La VS media fue 4,38 ± 0,43 cps en el grupo de sala, 4,53 ± 0,39 cps en los pacientes en UCI sin SS, y 4,85 ± 0,52 cps en los casos con SS, con diferencias estadísticamente significativas. Las mayores elevaciones de la VS en los casos con SS se detectaron entre los días 6 y 10 del ingreso hospitalario. En 2019 consultaron 4 casos, y otros 2 en 2020 sin diagnóstico de COVID-19, con valores normales de VS.
Durante la infección por SARS-Cov-2 los pacientes pueden presentar elevación en la VS y SS, si bien se hacen necesarios un grupo control hospitalario y un volumen muestral mayor para confirmar la predisposición a la hiperviscosidad. La incidencia del daño auditivo resulta considerable si se tiene en cuenta su posible aparición en pacientes críticos con COVID-19.</abstract><cop>Spain</cop><pub>Elsevier España, S.L.U</pub><pmid>35397819</pmid><doi>10.1016/j.otoeng.2022.02.004</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2173-5735 |
| ispartof | Acta otorrinolaringológica española (English), 2022-03, Vol.73 (2), p.104-112 |
| issn | 2173-5735 2173-5735 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8864080 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Blood Viscosity COVID-19 COVID-19 - complications Hearing Loss, Sudden - diagnosis Hearing Loss, Sudden - etiology Hipoacusia neurosensorial Humans Original Prospective Studies SARS-CoV-2 Sensorineural hearingloss Sordera súbita Sudden deafness Viscosidad sanguínea |
| title | Blood Viscosity in COVID-19 Patients With Sudden Deafness |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A51%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%20Viscosity%20in%20COVID-19%20Patients%20With%20Sudden%20Deafness&rft.jtitle=Acta%20otorrinolaringol%C3%B3gica%20espa%C3%B1ola%20(English)&rft.au=Garc%C3%ADa-Callejo,%20Francisco%20Javier&rft.date=2022-03&rft.volume=73&rft.issue=2&rft.spage=104&rft.epage=112&rft.pages=104-112&rft.issn=2173-5735&rft.eissn=2173-5735&rft_id=info:doi/10.1016/j.otoeng.2022.02.004&rft_dat=%3Cproquest_pubme%3E2649256625%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2649256625&rft_id=info:pmid/35397819&rft_els_id=S2173573522000278&rfr_iscdi=true |